We recently had an opportunity to sit down with Tunnell’s John Tegeris to learn more about BARDA (Biomedical Advanced Research & Development Authority) and its TechWatch Program. John joined Tunnell in 2006 and has been dedicated to supporting BARDA since then in a number of roles, including
management of theTechWatch Program.
As Trade War Continues, Pharma Companies Prepare for Alternatives
How will unpredictable tariffs and a trade war with China impact the pharmaceutical industry and the cost of life-saving drugs? Tunnell’s Bill Connell answers that question in his article, “As trade war continues, pharma companies prepare for
alternatives,” published in Supply Chain Brain. There is a risk that could result in higher costs and shortages throughout the entire US healthcare system, and pharma companies need to be prepared.
Data integrity is one of the most important driving factors in our industry’s success, and Tunnell’s Kip Wolf’s thought leadership on this topic has now been compiled into an e-book by Pharmaceutical Online. This timely and informative collection
reinforces the importance of quality culture, and the series starts with Kip’s article, “When and how to implement data integrity practices in the product development lifecycle.” In that first piece, Kip says that when data integrity is established early in the cycle, it informs later clinical research. Other articles in the e-book cover improvement opportunities for data integrity with specific examples and case studies. This e-book contains many real-world examples and concise explanations of topics on data integrity across all life sciences segments.
Bill Connell brings over 30 years of experience to Tunnell with both consulting and pharmaceutical operations experience in Life Sciences in the areas of supply chain strategy and optimization, operational excellence and technology solutions such as ERP and product serialization and
e-pedigree. His leadership skills and specialized insights have consistently delivered positive results, operational improvements and improved client profitability and performance.
Prior to joining Tunnell in 2019, Bill was President and Managing Director of WD Connell Consulting where he worked with leading pharmaceutical and biotechnology companies on strategy, supply chain optimization, technology solutions and operational excellence. He was also VP, Consulting at Maxiom Group Consulting (which was acquired by Collaborative Consulting LLC), Sr. VP of Global Operations at Iroko Pharmaceuticals/Iroko Cardio LLC where he oversaw the QA, IT, Supply Chain, Tech Ops and Product Development operations,
managing over 30 global CMOs and partners. Bill also worked at Tunnell previously as Supply Chain Practice Director and was part of the leadership team during Tunnell’s growth in Life Sciences.
In his spare time Bill returns to his roots in Maine where he hones his skills as a nature photographer.
Where We've Been, Where We're Going...
Data Integrity Conference- March 4-5, 2019 in Boston, MA Tunnell Principal Kip
Wolf spoke on "Regulatory Guidance for Data Integrity"
Life Sciences PA - Leadership Panel - Feb. 2019 - King of Prussia, PA Tunnell Consulting sponsored a leadership panel on "Leadership in Emerging Companies and the Changing Business Landscape". Life Sciences PA - Annual
Dinner - March 13, 2019 - Philadelphia, PA Tunnell Consulting sponsored the Board of Directors Reception
Life Sciences PA - Life Sciences Future - BioPharm - Oct. 3, 2109 - King of Prussia, PA Tunnell Consulting Principal Kati Abraham was on the planning committee
Life Sciences PA - Supply Chain Summit -
Oct. 29, 2019 - Villanova, PA Tunnell Consulting Principal Bill Connell was on the planning committee
Life Sciences PA - Annual CFO Dinner - Nov. 7, 2019 - St. Davids, PA Tunnell Consulting was a sponsor of this event
- - - - - - - - - - -
Penn State College of Medicine - Career Day - Oct. 19, 2019 - Hershey, PA Tunnell Principal Kip Wolf participated on a panel discussing opportunities in consulting
- - - - - - - - - - -
Johns Hopkins Medicine and Uniformed Services University - April 2-4, 2020 Tunnell Government Service's Paul Eder will chair a session on "Modern Techniques in ncRNA Research"
We Hope To See You At Upcoming Events!
In Memoriam
Michael E. Thomas
It is with great sadness that we announce the passing of our colleague and friend, Michael E. Thomas.Mike was an accomplished
statistician with global experience who was highly respected by both his peers and his clients.Prior to joining Tunnell, he supported Operations, Quality, Research & Development, Technical Services and Supply Chain with Teva Pharmaceuticals, Merck & Co. Inc., Johnson & Johnson and General Foods Corporation.
Mike devoted his professional career to the life sciences industry and was known for his integrity and dedication – and we are all the better for it.He will be deeply missed.
Dr. Arthur Y. Elliott
We are deeply saddened to also announce the passing of Dr. Arthur Y. Elliott. Art was an experienced senior scientist who spent almost 50 years working in the vaccine industry. He was instrumental in supporting the Bureau of Advanced Research and
Development Authority (BARDA) for a number of years in the area of influenza pandemic preparation.
In 2008 Art was presented the Health and Human Services award for his outstanding contribution to insure national pandemic influenza preparedness. He was well respected across all of ASPR/BARDA and will be remembered for his dedication to the life sciences industry.
